`

Seres Therapeutics

Biotechnology Research

Specialities :
Biotechnology
Therapeutics
And microbiome
revenue-icon Revenue
101M - 500M
funding-icon Total Funding
$110.0M
size-icon Size
201 - 500

Frequently Asked Questions About Seres Therapeutics

What does Seres therapeutics do?+

Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestle Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in medically compromised patients. We...

What are Seres therapeutics's specialties? +

Biotechnology,therapeutics,and microbiome

What is Seres therapeutics's industry? +

Seres therapeutics operates in the Biotechnology research industry.

What is Seres therapeutics's revenue? +

Seres therapeutics's revenue is 101m - 500m

What is Seres therapeutics's company size? +

Seres therapeutics has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.